Michael Rice's most recent trade in Orrstown Financial Services, Inc. was a trade of 1,500 Orrstown Financial Services, Inc. Common, Restricted Stock done . Disclosure was reported to the exchange on May 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orrstown Financial Service... | Michael John Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 1,500 | 2,500 (0%) | 0% | 0 | Orrstown Financial Services, Inc. Common, Restricted Stock | |
| Orrstown Financial Service... | Michael John Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 1,000 | 1,000 (0%) | 0% | 0 | Orrstown Financial Services, Inc. Common, Restricted Stock | |
| Orrstown Financial Service... | Michael John Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 1,500 | 4,641 | - | 0 | Orrstown Financial Services, Inc. Common, Restricted Stock | |
| Utz Brands Inc - Ordinary ... | Michael W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 7,420 | 9,615 | - | 0 | Class A Common Stock | |
| Utz Brands Inc - Ordinary ... | Michael W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 2,195 | 2,195 | - | 0 | Class A Common Stock | |
| Orrstown Financial Service... | Rice Michael John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 1,030 | 3,141 | - | 0 | Orrstown Financial Services, Inc., Common, Restricted Stock | |
| Biolife Solutions Inc | Michael Rice | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2023 | 1,248 | 418,154 (2%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.99 per share. | 25 Aug 2023 | 1,729 | 416,906 (2%) | 0% | 11.0 | 19,002 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 14 Aug 2023 | 277 | 418,635 (2%) | 0% | 12.4 | 3,429 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.91 per share. | 27 Jun 2023 | 877 | 418,912 (2%) | 0% | 22.9 | 20,092 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.21 per share. | 31 May 2023 | 1,679 | 419,789 (2%) | 0% | 23.2 | 38,970 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 21.04 per share. | 15 May 2023 | 33,333 | 421,468 (2%) | 0% | 21.0 | 701,326 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 18.71 per share. | 15 May 2023 | 190 | 454,801 (2%) | 0% | 18.7 | 3,555 | Common Stock |
| Orrstown Financial Service... | Michael John Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,000 | 2,111 | - | 0 | Orrstown Financial Services, Inc., Common, Restricted Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 7,511 | 458,205 (2%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 7,511 | 0 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 31 Mar 2023 | 3,214 | 454,991 (2%) | 0% | 20.0 | 64,376 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 29 Mar 2023 | 936 | 450,694 (2%) | 0% | 20.6 | 19,300 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 22.95 per share. | 07 Mar 2023 | 549 | 451,630 (2%) | 0% | 23.0 | 12,600 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 01 Mar 2023 | 4,290 | 452,179 (2%) | 0% | 22.8 | 97,598 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 24.60 per share. | 09 Feb 2023 | 144 | 456,469 (2%) | 0% | 24.6 | 3,542 | Common Stock |
| Orrstown Financial Service... | Michael John Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 1,111 | 3,163 | - | 0 | Orrstown Financial Services, Inc. Common, Restricted Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 99,038 | 456,613 (2%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 99,038 | 99,038 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 19.93 per share. | 29 Nov 2022 | 931 | 358,473 (1%) | 0% | 19.9 | 18,555 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Nov 2022 | 2,750 | 359,404 (1%) | 0% | 0 | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.16 per share. | 10 Nov 2022 | 164 | 362,154 (1%) | 0% | 23.2 | 3,798 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.44 per share. | 31 Aug 2022 | 906 | 363,148 (1%) | 0% | 23.4 | 21,237 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2022 | 504 | 364,054 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 10 Aug 2022 | 171 | 363,550 (1%) | 0% | 23.2 | 3,962 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 643 | 363,721 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2022 | 779 | 363,078 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2022 | 847 | 362,299 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 14.86 per share. | 28 Jun 2022 | 889 | 361,452 (1%) | 0% | 14.9 | 13,211 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2022 | 899 | 362,341 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2022 | 901 | 361,442 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 14.53 per share. | 27 May 2022 | 749 | 360,541 (1%) | 0% | 14.5 | 10,883 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2022 | 964 | 361,290 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 12.32 per share. | 13 May 2022 | 165 | 360,326 (1%) | 0% | 12.3 | 2,033 | Common Stock |
| Orrstown Financial Service... | Michael John Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 1,000 | 4,499 | - | 0 | Orrstown Financial Services, Inc. Common, Restricted Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 17.59 per share. | 18 Apr 2022 | 24,400 | 360,491 (1%) | 0% | 17.6 | 429,196 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2022 | 57,736 | 0 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2022 | 57,736 | 384,891 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2022 | 10,000 | 70,000 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2022 | 10,000 | 60,000 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 19.06 per share. | 11 Apr 2022 | 10,000 | 384,891 (1%) | 0% | 19.1 | 190,600 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.90 per share. | 11 Apr 2022 | 10,000 | 394,891 (1%) | 0% | 1.9 | 19,000 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 19.55 per share. | 11 Apr 2022 | 10,000 | 327,155 (1%) | 0% | 19.6 | 195,500 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.90 per share. | 11 Apr 2022 | 10,000 | 337,155 (1%) | 0% | 1.9 | 19,000 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 22.24 per share. | 29 Mar 2022 | 830 | 327,155 (1%) | 0% | 22.2 | 18,459 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.80 per share. | 07 Mar 2022 | 10,000 | 327,985 (1%) | 0% | 23.8 | 238,000 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 10,000 | 80,000 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 10,000 | 90,000 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.81 per share. | 07 Mar 2022 | 10,000 | 327,985 (1%) | 0% | 23.8 | 238,100 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.90 per share. | 07 Mar 2022 | 10,000 | 337,985 (1%) | 0% | 1.9 | 19,000 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.90 per share. | 07 Mar 2022 | 10,000 | 337,985 (1%) | 0% | 1.9 | 19,000 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.78 per share. | 01 Mar 2022 | 874 | 257,891 (1%) | 0% | 23.8 | 20,784 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 70,094 | 70,094 | - | - | Restricted Stock Award | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 70,094 | 328,859 (1%) | 0% | - | Common Stock | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 29.38 per share. | 10 Feb 2022 | 690 | 258,765 (1%) | 0% | 29.4 | 20,272 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 16,670 | 0 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 03 Feb 2022 | 16,670 | 276,125 (1%) | 0% | 1.8 | 29,673 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 27.84 per share. | 03 Feb 2022 | 16,670 | 259,455 (1%) | 0% | 27.8 | 464,093 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 16,666 | 16,670 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 29.90 per share. | 01 Feb 2022 | 16,666 | 259,455 (1%) | 0% | 29.9 | 498,313 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 01 Feb 2022 | 16,666 | 276,121 (1%) | 0% | 1.8 | 29,665 | Common Stock |
| Orrstown Financial Service... | Michael John Rice | Director | Grant, award, or other acquisition of securities at price $ 25.20 per share. | 26 Jan 2022 | 1,052 | 3,499 | - | 25.2 | 26,510 | Orrstown Financial Services, Inc. Common, Restricted Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 16,666 | 50,002 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 31.72 per share. | 10 Jan 2022 | 16,666 | 259,455 (1%) | 0% | 31.7 | 528,646 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 30.83 per share. | 10 Jan 2022 | 16,666 | 259,455 (1%) | 0% | 30.8 | 513,813 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 10 Jan 2022 | 16,666 | 276,121 (1%) | 0% | 1.8 | 29,665 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 10 Jan 2022 | 16,666 | 276,121 (1%) | 0% | 1.8 | 29,665 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 16,666 | 33,336 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 39.37 per share. | 29 Dec 2021 | 928 | 259,455 (1%) | 0% | 39.4 | 36,535 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 13 Dec 2021 | 16,666 | 277,049 (1%) | 0% | 1.8 | 29,665 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.78 per share. | 13 Dec 2021 | 16,666 | 277,049 (1%) | 0% | 1.8 | 29,665 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2021 | 16,666 | 66,668 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2021 | 16,666 | 83,334 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 32.80 per share. | 13 Dec 2021 | 16,666 | 260,383 (1%) | 0% | 32.8 | 546,645 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 33.82 per share. | 13 Dec 2021 | 16,666 | 260,383 (1%) | 0% | 33.8 | 563,644 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 07 Dec 2021 | 11,464 | 271,847 (1%) | 0% | 1.6 | 18,801 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 11,464 | 0 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 35.15 per share. | 07 Dec 2021 | 11,464 | 260,383 (1%) | 0% | 35.2 | 402,960 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 07 Dec 2021 | 11,461 | 271,844 (1%) | 0% | 1.6 | 18,796 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 11,461 | 11,464 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 36.52 per share. | 07 Dec 2021 | 11,461 | 260,383 (1%) | 0% | 36.5 | 418,556 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 30 Nov 2021 | 957 | 260,383 (1%) | 0% | 37.6 | 35,974 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 02 Nov 2021 | 11,461 | 272,801 (1%) | 0% | 1.6 | 18,796 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 11,461 | 22,925 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 11,461 | 34,386 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 56.81 per share. | 02 Nov 2021 | 11,461 | 261,340 (1%) | 0% | 56.8 | 651,099 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 02 Nov 2021 | 11,461 | 272,801 (1%) | 0% | 1.6 | 18,796 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 54.72 per share. | 02 Nov 2021 | 11,461 | 261,340 (1%) | 0% | 54.7 | 627,146 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 14 Oct 2021 | 3,215 | 261,340 (1%) | 0% | 40.0 | 128,504 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 05 Oct 2021 | 11,461 | 276,016 (1%) | 0% | 1.6 | 18,796 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 11,461 | 45,847 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 11,461 | 57,308 | - | - | Employee Stock Option | |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 40.55 per share. | 05 Oct 2021 | 11,461 | 264,555 (1%) | 0% | 40.6 | 464,744 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 40.63 per share. | 05 Oct 2021 | 11,461 | 264,555 (1%) | 0% | 40.6 | 465,660 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 05 Oct 2021 | 11,461 | 276,016 (1%) | 0% | 1.6 | 18,796 | Common Stock |
| Biolife Solutions Inc | Michael Rice | Director, CEO | Sale of securities on an exchange or to another person at price $ 43.12 per share. | 28 Sep 2021 | 907 | 264,555 (1%) | 0% | 43.1 | 39,110 | Common Stock |